Valiant Navion™ VNMF4034C185TU (UDI 00763000100872)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMF4034C185TU VAL NAV FF TP · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 1
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00763000100872), received between May 23, 2022 and Apr 19, 2024 — classified as 1 death, 1 injury, 2 malfunctions.
The most frequently reported specific device problem is “Leak/Splash” (4 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Leak/Splash4
Patient problems
- No Clinical Signs, Symptoms or Conditions2
- Hematoma1
- Insufficient Information1
- Obstruction/Occlusion1
- Pneumonia1
- Vascular Dissection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryApr 19, 2024Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT (VNMF4034C185TU) WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A THORACIC AORTIC DISSECTION. THE PATIENT HAD AN EXISTING VALIANT CAPTIVIA (VAMF4040C150TU) THORACIC STENT GRAFT IMPLANTED 6 YEARS PREVIOULSY. IT WAS REPORTED CORE LAB REVIEW OF CT IMAGING TAKEN APPROXIMATELY 4 YEARS POST THE INDEX PROCEDURE SHOWED A TYPE IA (NEW) ENDOLEAK. THE MAX AORTIC DIAMETER WAS NOTED AS 89.1MM. THE IMAGING WAS NA FOR AORTIC ENLARGEMENT. NO STENT FRACTURE, STENT RING ENLARGEMENT OR STENT RING MIGRATION WAS OBSERVED. A REINTERVENTION WAS PERFORMED. THE CAUSE OF THE TYPE IA ENDOLEAK IS UNDETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: Insufficient Information
MAUDE report 19141811 ↗DeathJul 17, 2023Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A 70MM TAA. IT WAS REPORTED ONE DAY POST THE INDEX PROCEDURE, CT SHOWED THE FOLLOWING OBSERVATIONS: INTERNAL DEVELOPMENT OF A SHORT SEGMENT TYPE B DISSECTION / TYPE I ENDOLEAK ALONG PROXIMAL ORIGIN OF STENT. A 2.4X2.9 CM HEMATOMA MEDIAL TO THE LEFT DISTAL EXTERNAL ILIAC ARTERY AND A OCCLUSION OF THE ANTERIOR DIVISION OF THE LEFT MAIN RENAL ARTERY. IT IS UNKNOWN WHICH STENT GRAFT THE ENDOLEAK OCCURRED. THE PATIENT SUBSEQUENTLY EXPIRED APPROXIMATELY 1 MONTH POST THE INDEX PROCEDURE DUE TO PNEUMONIA. IT IS UNKNOWN WHEN THE PATIENT DEVELOPED THE PNEUMONIA. PER THE PHYSICIAN THE CAUSE OF THE EVENTS SEEN ON THE CT COULD NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT EXPIRED.
Patient problems: Hematoma; Obstruction/Occlusion; Pneumonia; Vascular Dissection
MAUDE report 17331324 ↗MalfunctionJun 30, 2023Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A TAA AND DISSECTION . IT WAS REPORTED CT IMAGING WAS PERFORMED ABOUT THREE AND HALF YEARS LATER . CORELAB HAVE REVIEWED THIS IMAGING AND IDENTIFIED AN UND ETERMINED TYPE ENDOLEAK. A FRACTURE WAS NOTED ON THE STENT GRAFT WITH SN (B)(6). STENT RING ENLARGEMENT WAS ALSO NOTED ON STENT GRAFT WITH (B)(6) , STENT RING 4 (+ 4.2) , STENT RING 5 (+7.3), STENT RING 6 (+7.1). NO STENT RING MIGRATION WAS NOTED. THE MAXIMUM AORTIC DIAMETER MEASURED 71.9MM. NO CAUSE WAS REPORTED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17237617 ↗MalfunctionMay 23, 2022Leak/Splash; Leak/Splash
VALIANT NAVION STENT GRAFTS WERE IMPLANTED DURING AN UNKNOWN ENDOVASCULAR PROCEDURE. IT WAS REPORTED THE PATIENT RETURNED FOR A FOLLOW-UP CT. AN UNKNOWN ENDOLEAK WAS IDENTIFIED. NO CAUSE AS PER PHYSICIAN WAS PROVIDED. NO ADDITIONAL CLINICAL SEQUALAE WAS PROVIDED AND THE PATIENT WILL BE MONITORED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14469308 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page